Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

~65 mi. (Grenoble, France, +96 more cities)

Centre Hospitalier Universitaire de Grenoble

Diffuse Large B-Cell Lymphoma, +1 more condition

brentuximab vedotin, +2 more drugs

chemotherapy, +1 more type

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

~65 mi. (Grenoble, France, +87 more cities)

Hopital Albert Michallon

ALK Fusion

Non-Small Cell Lung Carcinoma

brigatinib

targeted therapy

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

~66 mi. (La Tronche, France, +31 more cities)

Centre Hospitalier Universitaire de Grenoble

TNFRSF8 Deficient Expression

Adult T-Cell Leukemia/Lymphoma, +8 more conditions

brentuximab vedotin, +3 more drugs

chemotherapy, +2 more types

Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

~66 mi. (La Tronche, France, +25 more cities)

CHU de Grenoble Hopital Nord ( Site 2027)

Melanoma

coxsackievirus A21, +1 more drug

immunotherapy

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~91 mi. (Valence, France, +137 more cities)

Centre Hospitalier de Valence-Service de Dermatologie ( Site 0377)

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

~91 mi. (Cuneo, Italy, +64 more cities)

Azienda Ospedaliera S. Croce e Carle

ER Positive, +1 more biomarker

Breast Carcinoma

anastrozole, +2 more drugs

hormone therapy

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

~97 mi. (Orbassano, Italy, +93 more cities)

AOU San Luigi Gonzaga di Orbassano ( Site 0595)

Bladder Carcinoma, +1 more condition

cisplatin, +4 more drugs

chemotherapy, +3 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~97 mi. (Orbassano, Italy, +172 more cities)

Azienda Sanitaria Ospedaliera S Luigi Gonzaga

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

~97 mi. (Orbassano, Italy, +190 more cities)

AOU San Luigi Gonzaga

ATM Loss, +27 more biomarkers

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~97 mi. (Orbassano, Italy, +93 more cities)

Ospedale San Luigi Gonzaga ( Site 1405)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy

~97 mi. (Orbassano, Italy, +120 more cities)

A.O. UNIVERSITARIA S. LUIGI GONZAGA; Oncologia Medica

PD-L1 Expression (CPS >= 1), +5 more biomarkers

Infiltrating Bladder Urothelial Carcinoma

atezolizumab

immunotherapy

A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)

~97 mi. (Orbassano, Italy, +154 more cities)

Azienda Sanitaria Ospedaliera S Luigi Gonzaga; S.C.D.U. di Oncologia Toracica

ALK Alternative Transcription Site, +7 more biomarkers

Non-Small Cell Lung Carcinoma

alectinib, +2 more drugs

immunotherapy, +1 more type